Top 7 Wound Care Companies in Advanced Wound Care Market
.png)
Published: May 2024
These players are engaged in offering wound care products including dressings, bioengineered skins and dermal substitutes, and wound healing medical devices. We analyzed over 180 wound care companies that are focused on offering advanced wound care products / management solutions for the healthcare professionals to expedite the healing process of a wound. In this article, discover the 7 leading wound care companies and their portfolios in the advanced wound care market.
In the last decade, the healthcare sector has witnessed growth in the global chronic disease burden. This was followed by a rise in medicare spending, leading to substantial financial burden. Interestingly, wound care management emerged as a significant contributor to this economic hardship. Therefore, in order to address this challenge, innovators have gradually shifted towards developing innovative and technologically advanced wound care products, that allow effective and expedited wound care management. Further, in order to increase the adoption of advanced wound care products, stakeholders are actively integrating such products with automation tools, artificial intelligence and machine learning. These initiatives have led to the development of smart bandages and mobile-operated wound care products. Such innovation in the wound care domain, coupled with the growing partnership activity, the wound care market is anticipated to gain widespread popularity in the coming years.
Despite the potential of such solutions in enhanced wound care management, there are still some challenges associated with the adoption of such products / solutions, including competition from conventional wound care solutions, lack of awareness, and limited availability in developing nations. In this context, advanced wound care products / solutions providers are actively exploring advanced technologies and are heavily investing in research and development of advanced wound care solutions, demonstrating the huge revenue generation potential of utilizing these management solutions.
Roots Analysis has conducted an exhaustive study on Advanced Wound Care Market featuring the current market landscape and future opportunity for the wound care companies providing product / solution providers in the advanced wound care domain, over a span of 10 years.
Table of Contents
The top 7 advanced wound care companies are listed below (in alphabetical order):
Table 1: List of Top 7 Advanced Wound Care Companies
| S.No. | Advanced Wound Care Companies | Year of Establishment | Location of Headquarter (Country) |
Location of Headquarter (Region) |
| 1 | 3M | 1902 | US | North America |
| 2 | Coloplast | 1957 | Denmark | Europe |
| 3 | Ethicon (a subsidiary of Johnson & Johnson) | 1915 | US | North America |
| 4 | Fidia Farmaceutici | 1946 | Italy | Europe |
| 5 | Mölnlycke Health Care | 1849 | Sweden | Europe |
| 4 | Smith + Nephew | 1856 | UK | Europe |
| 5 | Zimmer Biomet | 1927 | US | Noth America |
Interested in exploring all 180+ Advanced Wound Care Companies?
Discover the Details on 7 Advanced Wound Care Companies
This article highlights the top 7 players to watch out for in this industry. These companies were chosen based on their company size (large and very large), year of establishment (between 1849 to 1963) and portfolio strength (offering at least two advanced wound care products). It is essential to note that the selection of top players can differ substantially according to the defined criteria.
3M, Created a Spin-Off for its Medical Business including Wound Care
 |
Headquartered in the US, 3M has expertise in offering products and services catering to the needs of several industries including healthcare, transportation, electronics, consumer needs and industrial safety. Within the healthcare domain, 3M is focused on surgical care, advanced wound care, oral care, and biopharmaceutical filtration. Further, within the advanced wound care domain, the company is primarily focused on the manufacturing of wound dressings, bioengineered skins, dermal substitutes, and medical devices for wound healing.
3M offers following types of advanced wound care products:
- Advanced Wound Care Dressing
- Wound Healing Medical Device
Advanced Wound Care Dressing: Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings and Composite Dressings
Wound Healing Medical Device: Negative Pressure Wound Therapy
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers and Venous Ulcers
Recent Developments:
- In April 2024, the company announced the completion of the spin-off of its healthcare business and launched Solventum Corporation, an independently operating company.
- In March 2024, the company announced the appointment of William Brown as the Chief Executive Officer and Michael Roman as the Executive Chairman for the company.
- In January 2024, the company received a grant of $34.2 million in order to develop a range of new solutions for prevention of infection, wound management and wound healing.
Further details on recent initiatives taken by 3M as well as other wound care companies have been provided in detail in the report.
Coloplast, Expanding its Wound Care Portfolio Through Acquisition
 |
Coloplast is a Denmark-based healthcare company, focused on the development of products for intimate healthcare needs. The company’s portfolio includes products for ostomy care, continence care, wound and skin care, voice and respiratory care, and interventional urology. Within the wound and skin care segment, the company is currently focused on manufacturing wound care dressings, and bioengineered skins and dermal substitutes. With a workforce of over 15,500 employees worldwide, Coloplast has its production facilities in China, Costa Rica, France, Germany, Hungary, and Sweden.
Coloplast offers following types of advanced wound care products:
- Advanced Wound Care Dressing
- Bioengineered Skins and Dermal Substitute
Advanced Wound Care Dressing: Foam Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings and Composite Dressings
Bioengineered Skin and Dermal Substitute: Allografts
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Other Types of Acute Wounds and Other Types of Chronic Wounds
Recent Developments:
- In January 2024, the company announced the launch of Biatain® Silicone Fit, a silicone foam for pressure injury prevention and wound management, specifically in the US.
- In July 2023, the firm acquired Kerecis, in order to expand its advanced wound care portfolio in bioengineered and dermal substitutes.
Further details on recent initiatives taken by Coloplast as well as other wound care companies have been provided in detail in the report.
Ethicon (A Subsidiary of Johnson & Johnson), Launching its Hemostatic Sealing Patch in the European Market
 |
Based in New Jersey, Ethicon is a wholly-owned subsidiary of Johnson & Johnson MedTech. The company’s current portfolio includes products that can be utilized for hemostasis, reflux management, tumor microwave ablation, surgical stapling, wound closure, and medical robotics. In addition, the company has developed groundbreaking medical device technologies / platforms in order to assist the healthcare practitioners for the management of various clinical conditions. These include ENSEAL® X1 Tissue Sealer, MONARCH® Robotic Platform, and NeuWave™ Microwave Ablation System. Within the wound care segment, the company is currently focused on the manufacturing of wound care dressings and skin closure systems for the treatment and management of various types of acute wounds.
Ethicon offers following types of advanced wound care products:
- Advanced wound care dressing
- Wound healing medical device
Advanced Wound Care Dressing: Other types of wound care dressings
Wound Healing Medical Device: Skin Closure Systems / Adhesives
Types of Wounds Treated: Surgical Wounds
Recent Developments:
- In February 2024, the company announced the publication of two studies featuring insights from 20 orthopaedic surgeons on best approaches for wound closure and dressing management for total knee arthroplasty and total hip arthroplasty in The Journal of Arthroplasty.
- The company plans to launch Ethizia, its hemostatic sealing patch in the EU markets in 2024.
Further details on recent initiatives taken by Ethicon as well as other wound care companies have been provided in detail in the report.
Fidia Farmaceutici, Creating Solutions to Improve Quality of Life
 |
Fidia Farmaceutici is an Italy-based healthcare company focused on the development of products pertaining to joint care, skin care, eye care, aesthetic care, and specialty care. It is worth highlighting that the company’s product portfolio comprises of prescription drugs, medical devices and vaccines for various clinical conditions. With more than 1,600 employees and sales across the various geographical regions, Fidia Farmaceutici is one of the leading global manufacturers of hyaluronic acid-based products. Within the wound care segment, the company is currently focused on the development of wound care dressings, and bioengineered skins and dermal substitutes.
Fidia Farmaceutici offers following types of advanced wound care products:
- Advanced Wound Care Dressing
- Bioengineered Skins and Dermal Substitute
Advanced Wound Care Dressing: Foam Dressings, Alginate Dressings and Hydrocolloid Dressings
Bioengineered Skin and Dermal Substitute: Allografts and Other Types of Dermal Substitutes (Autologous Bioactive Therapy)
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Other Types of Acute Wounds and Other Types of Chronic Wounds
Recent Developments:
In August 2020, the company announced the expansion of its Austria branch, in order to expand its product portfolio from joint care, hyaluronic acid-based products for intra-articular injection to regenerative medicines. Using its expertise, the company aims to expand its products and services across various geographical regions. With an aim to establish a sustainable, and a system-driven healthcare organization that delivers a vast range of high-quality advanced wound care products, we expect the company to continue offering innovative advanced wound care products and solutions to cater to the growing demand across the globe.
Further details on recent initiatives taken by Fidia Farmaceutici as well as other wound care companies have been provided in detail in the report.
Molnlycke Health Care, Consolidates its Presence in the Wound Care Market
 |
Molnlycke Health Care is a Sweden-based medical device company, headquartered in Gothenburg. The company offers various products for wound care management and surgical requirements, including incision care, biogel gloves, barrier staff clothing and hibiclens skin cleansers. Moreover, the company supports its customers by providing solutions pertaining to pressure injury management, infection prevention, safe patient handling and clinician safety. Within the advanced wound care segment, the company is focused on the development and manufacturing of wound care dressings and wound healing medical devices for both acute and chronic wounds.
Molnlycke Health Care offers following types of advanced wound care products:
- Advanced wound care dressing
- Wound healing medical device
Advanced Wound Care Dressing: Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Alginate Dressings and Composite Dressings
Wound Healing Medical Device: Negative Pressure Wound Therapy and Positive Air Displacement Therapy
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Other Types of Acute Wounds and Other Types of Chronic Wounds
Recent Developments:
- In April 2024, the company entered into an agreement to acquire P.G.F. Industry Solutions, a manufacturer of wound cleansing and moisturizing solutions in order to strengthen its position in the global wound care market. P.G.F. Industry Solutions manufactures Granudacyn, which has been distributed by Molnlycke.
- In September 2023, the company participated in the 14th Asia-Pacific Burn Congress 2023, held in Chongqing, China.
- Further, in September 2023, the company participated in the European Pressure Ulcer Advisory Panel, held in Leeds, UK.
Further details on recent initiatives taken by Molnlycke Health Care as well as other wound care companies have been provided in detail in the report.
Smith+Nephew, Focused on Negative Pressure Based Wound Care Amongst Other Novel Areas
 |
Smith+Nephew is a UK-based company, focused on the development of solutions for orthopedics, sports medicine, ear, nose and throat (ENT) and advanced wound care. Within the advanced wound care segment, the company is actively engaged in the development of wound care dressings, bioengineered skins and dermal substitutes, and wound healing medical devices.
Smith+Nephew offers following types of advanced wound care products:
- Advanced Wound Care Dressing
- Bioengineered Skins and Dermal Substitute
- Wound Healing Medical Device
Advanced Wound Care Dressing: Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings, Composite Dressings and Other Advanced Wound Care Dressings
Bioengineered Skins and Dermal Substitute: Allografts
Wound Healing Medical Device: Negative Pressure Wound Therapy
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers and Venous Ulcers
Recent Developments:
- In April 2024, the company announced the launch of its negative pressure wound therapy system, RENASYS EDGE intended for the treatment of chronic wounds.
- In the same month, company also published a study on ALLEVYN LIFE foam dressing, its negative pressure wound dressing.
Further details on recent initiatives taken by Smith + Nephew as well as other wound care companies have been provided in detail in the report.
Zimmer Biomet, Amongst the Leading Wound Care Companies With its Broad Portfolio
 |
Zimmer Biomet is a technology-driven company that specializes in the designing, manufacturing and offering of innovative orthopedic solutions to the clinicians in order to restore mobility and improve the quality of patient’s life. The company offers a comprehensive product portfolio designed for reconstruction of various body parts (including elbow, foot and ankle, hip, knee and shoulder). Within the advanced wound care segment, the company currently offers wound care dressings, bioengineered skins and dermal substitutes, and wound healing medical devices.
Zimmer Biomet offers following types of advanced wound care products:
- Advanced Wound Care Dressing
- Bioengineered Skins and Dermal Substitute
- Wound Healing Medical Device
Advanced Wound Care Dressing: Other Types of Wound Care Dressings
Bioengineered Skins and Dermal Substitute: Allografts
Wound Healing Medical Device: Negative Pressure Wound Therapy and Hydrotherapy
Types of Wounds Treated: Surgical Wounds, Burns, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Other Types of Acute Wounds and Other Types of Chronic Wounds
Recent Developments:
- In January 2024, the company announced the appointment of Louis Shapiro to the company’s board of directors.
- In December 2023, the company participated in 42nd Annual J.P Morgan Healthcare Conference, held in San Francisco, California.
Further details on recent initiatives taken by Zimmer Biomet as well as other wound care companies have been provided in detail in the report.
What About the Other Advanced Wound Care Companies?
The above presentation features 7 advanced wound care companies selected from a pool of over 180 product providers that we have compiled. If you are interested, you can download the Sample Report on “Advanced Wound Care Market” by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources:
- “3M has expertise in offering products”
- “Solventum Corporation”
- “appointment of William Brown”
- “grant of $34.2 million”
- “30 countries”
- “Biatain® Silicone Fit”
- “Kerecis”
- “Journal of Arthroplasty”
- “P.G.F. Industry Solutions”
- “14th Asia-Pacific Burn Congress 2023”
- “European Pressure Ulcer Advisory Panel”
- “more than 100 countries”
- “RENASYS EDGE”
- “cooperative research and development agreement”
- “more than 100 countries”
- “Louis Shapiro”
- “42nd Annual J.P Morgan Healthcare Conference”